Tianjin Ringpu Bio-Technology Co.,Ltd.

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 07/05/2024 am IST			5-day change	1st Jan Change
17.02 ^CNY	+3.15%		+3.84%	+3.84%

29/04	Tianjin Ringpu Bio-Technology Co.,Ltd. completed the acquisition of Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership).	CI
25/04	Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Tianjin Ringpu Bio-Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023

June 03, 2023 at 01:03 am IST

Tianjin Ringpu Bio-Technology Co.,Ltd. announced 2022 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 3.00000000. Record date: 07 June 2023 Ex-date: 08 June 2023 Payment date: 08 June 2023.

Latest news about Tianjin Ringpu Bio-Technology Co.,Ltd.

Tianjin Ringpu Bio-Technology Co.,Ltd. completed the acquisition of Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership).	29/04	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Dividend for the Year 2023	02/04	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) for CNY 230 million.	30/03	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.	26/01	CI
Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on October 27, 2023, has closed with 3,689,608 shares, representing 0.8% for CNY 59.99 million.	25/01	CI
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.	02/01	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. announces an Equity Buyback for CNY 80 million worth of its shares.	26/23/26	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. authorizes a Buyback Plan.	26/23/26	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/23/25	CI
Luzhu Biotechnology Ties Up With Tianjin Ringpu to Develop Pet Vaccines, Drugs	26/23/26	MT
Beijing Luzhu Biotechnology Co., Ltd. and Tianjin Ringpu Bio-Technology Co., Ltd. Announces Strategic Cooperation Framework Agreement	26/23/26	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023	03/23/03	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend for 2022	25/23/25	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2022	03/23/03	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. signed an agreement to acquire 15% stake in Fujian Sunvet Biotechnology Co., Ltd. from Guo Haiyan and 16 natural person shareholders for CNY 63 million.	21/23/21	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces Executive Appointments	15/22/15	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces Cash Dividend of A Shares for 2021, Payable on 13 June 2022	08/22/08	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/22/28	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend for the Year 2021	20/22/20	CI

Chart Tianjin Ringpu Bio-Technology Co.,Ltd.

Duration

Period

Chart Tianjin Ringpu Bio-Technology Co.,Ltd.

More charts

Company Profile

TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD is a China-based company principally involved in the research, development, manufacture and sales of biological products and preparations for veterinary uses. The Company operates through two main segments. The Veterinary Use Biological Products segment is mainly involved in the manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic products and other biological products. The Veterinary Preparations segment is mainly involved in the manufacture and sales of chemical preparations, veterinary Chinese medicine and other preparations.

Sector

Pharmaceuticals

Calendar

23/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Tianjin Ringpu Bio-Technology Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.02 CNY

Average target price

21.14 CNY

Spread / Average Target

+24.18%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	+3.84%	1.09B
ELANCO ANIMAL HEALTH INCORPORATED	-9.26%	6.66B
BLUESTAR ADISSEO COMPANY	+27.25%	3.78B
VIRBAC	-2.50%	3.14B
VIMIAN GROUP AB	+11.32%	1.59B
JINYU BIO-TECHNOLOGY CO., LTD.	-14.30%	1.43B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-23.61%	1.28B
WUHAN KEQIAN BIOLOGY CO.,LTD	-9.13%	1.2B
VETOQUINOL SA	-6.45%	1.22B
SWEDENCARE AB	-11.91%	796M

Veterinary Drugs